ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced it will release its third quarter 2021 financial results on November 1, 2021, at 8:30 a.m. ET. The call will be hosted by President and CEO Nikhil Lalwani and Senior VP and CFO Stephen P. Carey. Investors can access the live webcast at www.anipharmaceuticals.com, where a replay will also be available. The company focuses on developing, manufacturing, and marketing both branded and generic pharmaceuticals, aiming for sustainable growth through various initiatives in the bio-pharmaceutical sector.

Positive

• Scheduled release of Q3 2021 results indicates ongoing operations
• Focus on sustainable growth through multiple business initiatives

Negative

• None.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date			Monday, November 1, 2021
Time			8:30 a.m. ET
Toll free (U.S.)			877-876-9173
Webcast (live and replay)			www.anipharmaceuticals.com, under the “Investors" section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for one-week by dialing 800-938-2243 and entering access code 6513021.

About ANI

ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211029005532/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals release its Q3 2021 financial results?

ANI Pharmaceuticals will release its Q3 2021 financial results on November 1, 2021.

What time is the ANI Pharmaceuticals conference call?

The ANI Pharmaceuticals conference call will take place at 8:30 a.m. ET on November 1, 2021.

How can I listen to the ANI Pharmaceuticals conference call?

You can listen to the ANI Pharmaceuticals conference call live at www.anipharmaceuticals.com under the 'Investors' section.

Who will host the ANI Pharmaceuticals conference call?

The conference call will be hosted by Nikhil Lalwani, President and CEO, and Stephen P. Carey, Senior VP and CFO.

Will there be a replay of the ANI Pharmaceuticals conference call?

Yes, a replay will be available within two hours of the call's completion and accessible for one week.